Clinical Trial

For information on the clinical trial and how to enroll, please click here. Alternatively, submit your name and contact information here. Enrollment for the next group of patients begins 2/1/2023.

Early news on the trial:

Bionic Sight Reports Meaningful Vision Improvements for RP Patients Receiving Highest Dose of its Emerging Optogenetic Therapy

Foundation Fighting Blindness, April 21, 2023

Positive Interim Results in Bionic Sight's Optogenetic Gene Therapy Trial

Presentation at conference entitled, "Gene Therapy for Ophthalmic Disorders", Sept, 2021

First Four Patients in Bionic Sight's Optogenetic Gene Therapy Trial Are Able to Detect Light and Motion

GlobeNewswire, March 30, 2021

For other related news, click here.